Supplement Industry’s ‘Golden Age’ Hits a Regulatory Wall

Supplement industry regulatory oversight intensified in early 2026, with MAHA priorities driving FDA modernization, state legislation, and mounting litigation pressure.

Supplement industry regulatory oversight intensified in early 2026, with MAHA priorities driving FDA modernization, state legislation, and mounting litigation pressure.

FDA warning letters are climbing in 2026, and food-industry operators ignoring the trend may be next in line.

The FDA state communication gap is widening. AFDO's executive director says the agency is withholding data that states themselves originally collected.